LLVK
LLVK is a selective IκB phosphorylation inhibitor. LLVK reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) . LLVK is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].
Product Specifications
CAS Number
798540-36-0
UNSPSC
12352209
Target
IKK; NF-κB
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
NCCCC[C@@H](C(O)=O)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@@H](N)CC(C)C)=O)=O)=O
Molecular Formula
C23H45N5O5
Molecular Weight
471.63
References & Citations
[1]Liu W, et al. Alternation in sequence features and their influence on the anti-inflammatory activity of soy peptides during digestion and absorption in different enzymatic hydrolysis conditions. Food Chem. 2025 Apr 15;471:142824.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1285408-01 0.02 mg (E-Coli)
Recombinant Vibrio parahaemolyticus Shikimate kinase (aroK)
Sign In for Pricing
View Details MBS1285408-02 0.1 mg (E-Coli)
Recombinant Vibrio parahaemolyticus Shikimate kinase (aroK)
Sign In for Pricing
View Details MBS1285408-03 0.02 mg (Yeast)
Recombinant Vibrio parahaemolyticus Shikimate kinase (aroK)
Sign In for Pricing
View Details MBS1285408-04 0.1 mg (Yeast)
Recombinant Vibrio parahaemolyticus Shikimate kinase (aroK)
Sign In for Pricing
View Details MBS1285408-05 0.02 mg (Baculovirus)
Recombinant Vibrio parahaemolyticus Shikimate kinase (aroK)
Sign In for Pricing
View Details